The effect of gender in clinically isolated syndrome (CIS): A meta-analysis

Multiple Sclerosis Journal

Volumn 18, Issue 5, 2012, Pages 600-604

  Dobson, Ruth ^a   Ramagopalan, Sreeram ^a,b   Giovannoni, Gavin ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

demyelinating diseases; meta analysis; multiple sclerosis; natural history studies; risk factors

Indexed keywords

ARTICLE; DEMYELINATING DISEASE; DISEASE COURSE; GENDER BIAS; HUMAN; META ANALYSIS (TOPIC); MULTIPLE SCLEROSIS; OBSERVATIONAL STUDY; RISK ASSESSMENT;

EID: 84860434256     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458511426740     Document Type: Article

References (43)

1. Sadovnick A. European Charcot Foundation Lecture: the natural history of multiple sclerosis and gender. J Neurol Sci. 2009 ; 286: 1-5
2. Ebers G. Environmental factors and multiple sclerosis. Lancet Neurol. 2008 ; 7: 268-277
3. Greer JM, McCombe PA. Role of gender in multiple sclerosis: clinical effects and potential molecular mechanisms. J Neuroimmunol. 2011 ; 234: 7-18
4. Thrower B. Clinically isolated syndromes: predicting and delaying multiple sclerosis. Neurology. 2007 ; 68: S12-15
5. Chard DT, Dalton CM, Swanton J, et al. MRI only conversion to multiple sclerosis following a clinically isolated syndrome. J Neurol Neurosurg Psychiatry. 2011 ; 82: 176-179
6. Liu Y, Duan Y, Yu C, et al. Clinical isolated syndrome: A 3-year follow-up study in China. Clin Neurol Neurosurg. 2011 ;:
7. Ruet A, Deloire MS, Ouallet JC, et al. Predictive factors for multiple sclerosis in patients with clinically isolated spinal cord syndrome. Mult Scler. 2011 ; 17: 312-318
8. Bosca I, Magraner MJ, Coret F, et al. The risk of relapse after a clinically isolated syndrome is related to the pattern of oligoclonal bands. J Neuroimmunol. 2010 ; 226: 143-146
9. Brettschneider J, Czerwoniak A, Senel M, et al. The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS). PLoS One. 2010 ; 5: e11986
10. Di Filippo M, Anderson VM, Altmann DR, et al. Brain atrophy and lesion load measures over 1 year relate to clinical status after 6 years in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiatry. 2010 ; 81: 204-208
11. Oligoclonal bands and MRI in clinically isolated syndromes: predicting conversion time to multiple sclerosis. J Neurol. 2010 ; 257: 1188-1191
12. Swanton JK, Fernando KT, Dalton CM, et al. Early MRI in optic neuritis: the risk for clinically definite multiple sclerosis. Mult Scler. 2010 ; 16: 156-165
13. Tintore M, Rovira A, Arrambide G, et al. Brainstem lesions in clinically isolated syndromes. Neurology. 2010 ; 75: 1933-1938
14. Taylor BV, Lucas RM, Dear K, et al. Latitudinal variation in incidence and type of first central nervous system demyelinating events. Mult Scler. 2010 ; 16: 398-405
15. Brettschneider J, Tumani H, Kiechle U, et al. IgG antibodies against measles, rubella, and varicella zoster virus predict conversion to multiple sclerosis in clinically isolated syndrome. PLoS One. 2009 ; 4: e7638
16. Jafari N, Hoppenbrouwers I, Hop W, et al. Cigarette smoking and risk of MS in multiplex families. Mult Scler. 2009 ; 15: 1363-1367
17. Lo CP, Kao HW, Chen SY, et al. Prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis according to baseline MRI findings: comparison of revised McDonald criteria and Swanton modified criteria. J Neurol Neurosurg Psychiatry. 2009 ; 80: 1107-1109
18. Mowry EM, Pesic M, Grimes B, et al. Clinical predictors of early second event in patients with clinically isolated syndrome. J Neurol. 2009 ; 256: 1061-1066
19. Outteryck O, Zephir H, Defoort S, et al. Optical coherence tomography in clinically isolated syndrome: no evidence of subclinical retinal axonal loss. Arch Neurol. 2009 ; 66: 1373-1377
20. Young J, Quinn S, Hurrell M, Taylor B. Clinically isolated acute transverse myelitis: prognostic features and incidence. Mult Scler. 2009 ; 15: 1295-1302
21. Zephir H, Lefranc D, Dubucquoi S, et al. Serum IgG repertoire in clinically isolated syndrome predicts multiple sclerosis. Mult Scler. 2009 ; 15: 593-600
22. Di Pauli F, Reindl M, Ehling R, et al. Smoking is a risk factor for early conversion to clinically definite multiple sclerosis. Mult Scler. 2008 ; 14: 1026-1030
23. Jacobi C, Hahnel S, Martinez-Torres F, et al. Prospective combined brain and spinal cord MRI in clinically isolated syndromes and possible early multiple sclerosis: impact on dissemination in space and time. Eur J Neurol. 2008 ; 15: 1359-1364
24. Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up. Arch Neurol. 2008 ; 65: 727-732
25. Rocca MA, Agosta F, Sormani MP, et al. A three-year, multi-parametric MRI study in patients at presentation with CIS. J Neurol. 2008 ; 255: 683-691
26. Sellner J, Luthi N, Buhler R, et al. Acute partial transverse myelitis: risk factors for conversion to multiple sclerosis. Eur J Neurol. 2008 ; 15: 398-405
27. Greeve I, Sellner J, Lauterburg T, et al. Anti-myelin antibodies in clinically isolated syndrome indicate the risk of multiple sclerosis in a Swiss cohort. Acta Neurologica Scandinavica. 2007 ; 116: 207-210
28. Swanton JK, Rovira A, Tintore M, et al. MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol. 2007 ; 6: 677-686
29. Tomassini V, De Giglio L, Reindl M, et al. Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS. Mult Scler. 2007 ; 13: 1086-1094
30. Brettschneider J, Petzold A, Junker A, Tumani H. Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis. Mult Scler. 2006 ; 12: 143-148
31. Korteweg T, Tintore M, Uitdehaag B, et al. MRI criteria for dissemination in space in patients with clinically isolated syndromes: a multicentre follow-up study. Lancet Neurol. 2006 ; 5: 221-227
32. Masjuan J, Alvarez-Cermeno JC, Garcia-Barragan N, et al. Clinically isolated syndromes: a new oligoclonal band test accurately predicts conversion to MS. Neurology. 2006 ; 66: 576-578
33. Tintore M, Rovira A, Rio J, et al. Is optic neuritis more benign than other first attacks in multiple sclerosis?. Ann Neurol. 2005 ; 57: 210-215
34. Martinez-Yelamos A, Rovira A, Sanchez-Valle R, et al. CSF 14-3-3 protein assay and MRI as prognostic markers in patients with a clinically isolated syndrome suggestive of MS. J Neurol. 2004 ; 251: 1278-1279
35. Eriksson M, Andersen O, Runmarker B. Long-term follow-up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosis. Mult Scler. 2003 ; 9: 260-274
36. Sastre-Garriga J, Tintore M, Rovira A, et al. Conversion to multiple sclerosis after a clinically isolated syndrome of the brainstem: cranial magnetic resonance imaging, cerebrospinal fluid and neurophysiological findings. Multiple Sclerosis. 2003 ; 9: 39-43
37. Tintore M, Rovira A, Brieva L, et al. Isolated demyelinating syndromes: comparison of CSF oligoclonal bands and different MR imaging criteria to predict conversion to CDMS. Mult Scler. 2001 ; 7: 359-363
38. Hely MA, McManis PG, Doran TJ, et al. Acute optic neuritis: a prospective study of risk factors for multiple sclerosis. J Neurol Neurosurg Psychiatry. 1986 ; 49: 1125-1130
39. Sandberg-Wollheim M, Bynke H, Cronqvist S, et al. A long-term prospective study of optic neuritis: evaluation of risk factors. Ann Neurol. 1990 ; 27: 386-393
40. Soderstrom M, Ya-Ping J, Hillert J, Link H. Optic neuritis: prognosis for multiple sclerosis from MRI, CSF, and HLA findings. Neurology. 1998 ; 50: 708-714
41. Koch-Henriksen N, Sorensen PS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol. 2010 ; 9: 520-532
42. Orton S, Herrera B, Yee I, et al. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol. 2006 ; 5: 932-936
43. Koch-Henriksen N. Increasing incidence of multiple sclerosis in Danish women. Mult Scler. 2006 ; 12: S228